about
Negative pressure wound therapy for treating foot wounds in people with diabetes mellitusHepatitis C Infection Among Injecting Drug Users in England and Wales (1992-2006): There and Back Again?AplusB: A Web Application for Investigating A + B Designs for Phase I Cancer Clinical TrialsRoutine antenatal anti-D prophylaxis in women who are Rh(D) negative: meta-analyses adjusted for differences in study design and qualityMeta-analysis of the prevalence of renal cancer detected by abdominal ultrasonography.What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis.Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years.Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.An evidence synthesis approach to estimating Hepatitis C prevalence in England and Wales.Meta-analysis of rare and adverse event data.Toxicity-dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trials.Joint modelling of longitudinal and time-to-event data with application to predicting abdominal aortic aneurysm growth and ruptureObservations from the IMPROVE trial concerning the clinical care of patients with ruptured abdominal aortic aneurysm.Making predictions from complex longitudinal data, with application to planning monitoring intervals in a national screening programmeCost-effectiveness of the National Health Service Abdominal Aortic Aneurysm Screening Programme in EnglandThe clinical and cost-effectiveness of brief advice for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial.Patient reactions to a web-based cardiovascular risk calculator in type 2 diabetes: a qualitative study in primary care.The clinical effectiveness and cost-effectiveness of brief intervention for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial (SHEAR).Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C.HeLP-Diabetes: randomised controlled trial protocolEffects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trialA method making fewer assumptions gave the most reliable estimates of exposure-outcome associations in stratified case-cohort studiesBrief intervention for alcohol misuse in people attending sexual health clinics: study protocol for a randomized controlled trial.Using predictions from a joint model for longitudinal and survival data to inform the optimal time of intervention in an abdominal aortic aneurysm screening programme.Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis.Fully Bayesian hierarchical modelling in two stages, with application to meta-analysis.Modelling semi-attributable toxicity in dual-agent phase I trials with non-concurrent drug administrationRupture rates of small abdominal aortic aneurysms: a systematic review of the literature.Systematic review and meta-analysis of growth rates of small abdominal aortic aneurysms.Adaptive designs for dual-agent phase I dose-escalation studies.Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost-effectiveness.Sex differences in mortality after abdominal aortic aneurysm repair in the UK.Endovascular Repair of Abdominal Aortic Aneurysm in Patients Physically Ineligible for Open Repair: Very Long-term Follow-up in the EVAR-2 Randomized Controlled Trial.Association analyses based on false discovery rate implicate new loci for coronary artery disease.A comparison of Cox and logistic regression for use in genome-wide association studies of cohort and case-cohort design.Misspecification of at-risk periods and distributional assumptions in estimating COPD exacerbation rates: The resultant bias in treatment effect estimation.Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial.Incidence estimation using a single cross-sectional age-specific prevalence survey with differential mortality.Parity, breastfeeding and risk of coronary heart disease: A pan-European case-cohort study.
P50
Q24203018-109BA0AB-21D4-4A2B-B01C-6111F37D2D2BQ27488973-57CE4C42-B9D1-457D-BD71-67EFA40EB4FCQ28552571-03AF62E2-7648-4E9D-B388-D2DFC9EA1502Q28732243-583DAF5E-D724-4978-B0C0-A9245B79ED91Q30234820-486C1408-9316-4172-9595-7DC4FFE17EECQ30926358-4102B15F-0F37-4853-A6A3-D6680ECE96B0Q31126960-03D41C60-6433-4024-8403-7F9F0AA815B8Q31159544-CDFF0D45-0ECC-42E4-AC9F-BFD636A0C5D2Q33243658-1BAC4E92-A424-4384-9664-25290EC5732EQ33387534-FA7F0976-DDEA-4866-AC4D-7802AFCCB578Q33508895-750D342A-9147-46B0-AB10-0C167C00BB20Q33508895-AF9D5353-0AC1-437A-B62A-86B1F6DB2B6BQ33772533-AB1A0F3E-20E1-4A05-8C4A-FCA9D771AC57Q33990605-F978F331-7DD3-4C43-97A8-F02C6BD36B2AQ34182225-553B3A08-F9F0-4DED-9291-ACF5F6F162EAQ34373711-ADF75A46-5179-4AFC-BB88-E54570579EBDQ34507231-603E4065-5325-442C-8621-D62F0FFEB4FFQ35048625-FFC906BF-7F25-4768-B518-7A195B093F9EQ35110228-96F662B1-0110-455E-AAEB-FF1D034531A8Q35166004-1BBBDFD2-A56B-497A-B59B-0C51FE628B38Q35768976-1DEF4ADD-961D-4E7F-ADCA-73E9AFCBA197Q35881132-958FF564-17BA-470F-9FCE-17A6A6B542B9Q36150134-EFC1E0C6-73B0-48F5-B912-964FDCFE92C5Q36345777-5D9E1E8A-731E-45CE-8534-ACC3BFE42B39Q36350352-15C2E512-CFBC-44EF-B083-BE16AF8E0F67Q36354798-300F19E2-574B-4ECA-BF4A-6708F75B7C6AQ36382890-78696D66-FE08-4AA2-8049-B19691A36AF4Q37270164-971A548D-524F-422B-9E0E-F99FFF1F6D8FQ37505622-9676BDDC-BC4E-4D68-A0D1-CE7F4F835CEEQ37800718-5E57B333-A7F1-44E3-B317-F38E21E8BAABQ37853941-48B12AFA-364D-459D-AF81-44E628678DFDQ38090897-7F726877-7DCC-46C1-9587-585AE9A5D32EQ38143462-B05537AA-427B-400E-81FD-02BB8AD373EEQ38399644-6A3BAEE0-0474-41F8-990D-3F0167AB6C5FQ38662332-815CDFB1-4D91-40E4-8354-FF5AE3527ABEQ38675868-AAF41869-649A-4DE4-A85A-8EF2CCBDFBE9Q38736576-96F2BEF8-0FDE-4516-9510-BC79B5E74806Q39102942-EA386803-4B9C-4F29-AD58-F38E7AC51BB9Q39288758-AD18F24B-9996-49E9-9C46-792E32518316Q39354895-1C6E57D4-B270-4982-9405-6B4359EE9BEB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael J Sweeting
@ast
Michael J Sweeting
@en
Michael J Sweeting
@es
Michael J Sweeting
@nl
Michael J Sweeting
@sl
type
label
Michael J Sweeting
@ast
Michael J Sweeting
@en
Michael J Sweeting
@es
Michael J Sweeting
@nl
Michael J Sweeting
@sl
altLabel
Michael Sweeting
@en
Sweeting MJ
@en
prefLabel
Michael J Sweeting
@ast
Michael J Sweeting
@en
Michael J Sweeting
@es
Michael J Sweeting
@nl
Michael J Sweeting
@sl
P106
P21
P31
P3835
michael-sweeting2
P496
0000-0003-0980-8965